J Kurebayashi Selected Research

KF58333

12/2001	Stereospecific antitumor activity of radicicol oxime derivatives.
12/2001	A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Kurebayashi Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 01/2004 - 01/2000
11	Neoplasms (Cancer) 07/2004 - 01/2000
4	Neoplasm Metastasis (Metastasis) 01/2000 - 01/2000
3	Hypercalcemia (Milk Alkali Syndrome) 04/2001 - 01/2000
3	Papillary Thyroid Cancer 10/2000 - 04/2000
2	Thyroid Neoplasms (Thyroid Cancer) 07/2004 - 08/2000
2	Hypoxia (Hypoxemia) 12/2001 - 10/2001
2	Cachexia 10/2001 - 01/2000
1	Anaplastic Thyroid Carcinoma 07/2004
1	Genetic Translocation (Chromosomal Translocation) 09/2001
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2001
1	Papillary Carcinoma 10/2000
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2000
1	Ductal Carcinoma 02/2000
1	Osteolysis 01/2000
1	Body Weight (Weight, Body) 01/2000

Drug/Important Bio-Agent (IBA)

4	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2001 - 01/2000
4	Estrogen ReceptorsIBA 10/2001 - 01/2000
3	Proteins (Proteins, Gene)FDA Link 12/2001 - 02/2000
3	Messenger RNA (mRNA)IBA 10/2001 - 02/2000
3	Docetaxel (Taxotere)FDA Link 10/2001 - 01/2000
3	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 10/2001 - 01/2000
3	Thyroglobulin FDA Link 10/2000 - 04/2000
2	Pharmaceutical PreparationsIBA 07/2004 - 12/2001
2	Biological ProductsIBA 07/2004 - 12/2001
2	Fulvestrant (Faslodex)FDA Link 01/2004 - 01/2000
2	KF58333IBA 12/2001 - 12/2001
2	monorden (radicicol)IBA 12/2001 - 12/2001
2	Interleukin-6 (Interleukin 6)IBA 10/2001 - 01/2000
2	doxifluridineIBA 10/2001 - 01/2000
2	Estradiol (Delestrogen)FDA LinkGeneric 10/2001 - 08/2000
2	Estrogens (Estrogen)FDA Link 10/2001 - 01/2000
2	Hormones (Hormone)IBA 10/2001 - 08/2000
2	Progestins (Progestagens)IBA 10/2001 - 01/2000
2	Differentiation AntigensIBA 10/2000 - 04/2000
2	Iodide Peroxidase (Deiodinase)IBA 10/2000 - 04/2000
2	Thyrotropin Receptors (Thyrotropin Receptor)IBA 10/2000 - 04/2000
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2000 - 04/2000
2	Co-Repressor ProteinsIBA 03/2000 - 02/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2004
1	Phosphotransferases (Kinase)IBA 07/2004
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 07/2004
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2004
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2004
1	Therapeutic UsesIBA 07/2004
1	ErbB Receptors (EGF Receptor)IBA 01/2004
1	Gefitinib (Iressa)FDA Link 01/2004
1	Tyrosine Kinase InhibitorsIBA 01/2004
1	OximesIBA 12/2001
1	NucleotidesIBA 12/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2001
1	geldanamycinIBA 12/2001
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2001
1	TegafurIBA 10/2001
1	Thymidine PhosphorylaseIBA 10/2001
1	Cyclin D1IBA 09/2001
1	Cyclin D2IBA 09/2001
1	Epidermal Growth Factor (EGF)IBA 07/2001
1	Parathyroid Hormone-Related ProteinIBA 04/2001
1	PropionatesIBA 08/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2000
1	ovexIBA 08/2000
1	CytokinesIBA 08/2000
1	O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA 08/2000
1	Angiogenesis InhibitorsIBA 08/2000
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 07/2000
1	RNA (Ribonucleic Acid)IBA 04/2000
1	sodium-iodide symporter (sodium iodide symporter)IBA 04/2000
1	Estrogen Receptor betaIBA 02/2000
1	EnzymesIBA 02/2000
1	Estrogen Receptor alphaIBA 02/2000
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2000
1	factor AIBA 01/2000
1	InterleukinsIBA 01/2000
1	Trastuzumab (Herceptin)FDA Link 01/2000
1	Monoclonal AntibodiesIBA 01/2000
1	Aromatase InhibitorsIBA 01/2000

Therapy/Procedure

9	Therapeutics 01/2004 - 01/2000
1	Intravenous Injections 12/2001
1	Intraperitoneal Injections 10/2001
1	Brachytherapy 01/2000